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Abstract
In 1996, the first human case of infection by Rickettsia sibirica
subsp. mongolitimonae was described in France. Subsequently,
other human cases were reported in the same country. The
acronym LAR (lymphangitis-associated rickettsiosis) has been
proposed to designate this disease because lymphangitis is one
of the main clinical manifestations. Later, a few more cases were
described in Portugal, South Africa, Egypt, Greece and Spain.
We report a case of R. sibirica mongolitimonae infection as a
cause of septic shock in a Spanish patient living in La Rioja
(northern Spain). In addition, the broad clinical spectrum of this
tick-borne disease is discussed.
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Recently, Rickettsia sibirica mongolitimonae has been implicated
as the aetiological agent of human rickettsioses in the Medi-
terranean area [1]. The acronym LAR (lymphangitis-associ-
ated rickettsiosis) has been proposed to designate this
disease because lymphangitis is one of the main clinical mani-
festations. We describe here a case of septic shock caused
by this rickettsia species in Spain, and discuss the broad clini-
cal spectrum of this tick-borne disease.
A 69-year-old man was admitted to the Hospital San
Pedro in La Rioja (Spain) on September 2011, with a 4-day
history of fever, myalgia, headache and prostration. The
patient, who had hypertension, atrial fibrillation and mitral
regurgitation, was being treated with irbesartan (150 mg/
day), digoxin and acenocumarol. Seven days before, he had
returned from a 2-week vacation in a rural area in the
South-East of La Rioja. He was in contact with domestic ani-
mals but did not notice any tick bite.
On physical examination, his vital signs included: tempera-
ture, 39.9C; blood pressure, 80/60 mm Hg; heart rate,
120 beats/min. He had stupor. His mucous membranes
appeared normal. He had a purpuric rash on the trunk and
extremities, including palms and soles, and an eschar on his
left hip. No other signs or symptoms were observed on
examination.
The main laboratory findings on admission were as fol-
lows: leucocytes, 7300 with 88.5% neutrophils; haematocritic,
36%; platelets, 44 000/L; elevated levels of lactate, 28 mg/dL
(normal value, 5.7–22 mg/dL); and procalcitonin, 3.09 ng/mL
(normal value, £0.5 ng/mL); as well as elevated serum
creatinine, 1.51 mg/dL; aspartate aminotransferase, 388 IU/L;
alanine aminotransferase, 62 IU/L; gamma-glutamyl transpep-
tidase, 89 IU/L; creatine phosphokinase, 553 IU/dL; lactate
dehydrogenase, 900 IU/L; C reactive protein, 193 mg/L; arte-
rial pH, 7.35; pO2, 68 mm Hg; pCO2, 22 mmHg; and O2 sat-
uration, 94%. Blood culture and urine culture were ordered.
An EDTA-treated blood specimen was collected before anti-
biotic treatment to investigate the presence of Rickettsia spp.
using polymerase chain reaction (PCR) assays for gltA and
ompB rickettsial genes, as previously described [2]. A nega-
tive control (sterile water) and a positive control (DNA
from R. amblyommii) were included in each test.
In addition, acute and convalescent sera specimens (col-
lected a month after the onset of the illness) were tested by
immunofluorescence assays (IFA) using Rickettsia conorii as
antigen (BioMe´rieux, Marcy l’Etoile, France).
The chest radiograph did not show consolidation or other
abnormality. The abdominal ecography did not reveal any
abnormality.
Supportive therapy with fluids and inotropic agents, intra-
venous (IV) meropenem (1 g/8 h.), IV vancomycin (1 g/12 h.)
and IV doxycycline (100 mg/12 h.) was started.
After 2 days of treatment he was afebrile, alert and ori-
ented. His blood pressure was 100/60. His condition grad-
ually improved, except for the purpuric rash, which was
present during all hospitalization. The levels of lactate and
procalcitonine were rapidly normalized. The other labora-
tory abnormalities improved more slowly. Blood and urine
cultures were negative. DNA was extracted from blood
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using the DNeasy Blood and Tissue Kit (Qiagen, Hilden,
Germany), according to the manufacturer’s instructions.
Rickettsial DNA was detected by PCR assays targeting gltA
and ompB rickettsial genes. Nucleotide sequence analysis
(300 and 382 bp, respectively) showed 100% identity with
gltA and ompB from R. sibirica mongolitimonae. Partial
sequences for gltA and ompB generated in this study were
deposited in GenBank under accession Nos. JQ782656 and
JQ782657, respectively. Percentages of identity with R. co-
norii were 99.3% for gltA (298/300) and 98.9%, for ompB
(378/382). No IgG antibodies against R. conorii were found
in the acute serum specimen, whereas they were detected
at titre of 2048 in the convalescent one.
From January 1996 to June 2004, R. sibirica mongolitimonae
infections were reported in nine patients from France and
South Africa [1]. In these first descriptions, this tick-borne
rickettsiosis showed several epidemiological and clinical dif-
ferences with Mediterranean spotted fever (MSF). Many
cases occurred in spring and the main distinctive features
were the presence of enlarged lymph nodes in the territory
draining the eschar in five patients (55%), or lymphangitis
expanding from the eschar to the draining node in four of
them (44%), and multiple eschars in two patients.
To date, nine more cases have been published: one each
in South Africa, France, Greece and Egypt, two in Portugal,
and three in Spain (including the one herein described) [2–
9]. Unlike the previously published cases that occurred in
spring, most cases of infection herein reviewed (6/9) were
probably acquired in summer, during the seasonal peak of
MSF in some areas (i.e. northern Spain), except for two
patients that became ill in spring and one in winter. Lym-
phangitis, a clinical feature proposed as typical of R. sibirica
mongolitimonae infection, was only present in one-third of
patients (3/9). Multiple eschars, the other distinctive feature
of this tick-borne rickettsiosis, were not observed in any
case. A half of patients (4/9) exhibited clinical signs and
symptoms similar to MSF, and they occurred in 1 month
with high incidence of MSF. Epidemiological and clinical data
from these patients are shown in Table 1.
To our knowledge the vector is unknown, although R. sibi-
rica mongolitimonae has been associated with Hyalomma spp.
and Rhipicephalus pusillus ticks [4,5,10,11]. These ticks bite
more commonly in spring, corresponding with most
reported cases.
The patient herein described was originally diagnosed with
a severe form of MSF and this is the only reported case of
septic shock due to R. sibirica mongolitimonae.
It is not possible in rickettsiosis to implicate a rickettsia at
the species level based only on clinical manifestations,
because the same agent may cause different signs and symp-
toms. As for clinical presentation, patients with LAR have
been reported in France, Portugal and South Africa. Never-
theless, although lymphangitis is a very specific sign allowing
clinical diagnosis, it may be absent. Patients with R. sibirica
mongolitimonae infection exhibit a broad spectrum of clinical
syndromes with different degrees of severity. Furthermore,
infections caused by different Rickettsia spp. may cause the
same clinical syndrome. For instance, in Spain, in addition to
R. conorii, which is the main agent of MSF, MSF-like symptoms
may be, at least, caused by Rickettsia monacensis [12] or
R. sibirica mongolitimonae [2].
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TABLE 1. Epidemiological and clinical data of patients reported after those described by Fournier et al. in 2005
Patient 1 2 3 4 5 6 7 8 9 Percentage (%)
Sex Male Female Male Male Male Male Male Male Male 88.9 male
Age (years) 76 20 44 73 52 34 41 73 69 NA
Month of infection December June August August September September June August September NA
Tick-bite Yes No No No No Yes Yes Yes No NA
Country Greece France Portugal Portugal Egypt South Africa Spain Spain Spain NA
Temperature (ºC) 38.2 38.5 38.7 39.6 38.0 38.5 39.0 39.0 39.9 NA
Myalgias Yes Yes Yes Yes Yes Yes Yes Yes Yes 100
Headache Yes Yes Yes Yes Yes Yes Yes Yes Yes 100
Eschar (number) Yes (1) Yes (1) Yes (1) Yes (1) Yes (1) Yes (1) No Yes (1) Yes (1) 88.9
Lymphadenopathy Yes Yes Yes No No Yes No No No 44.4
Lymphangitis No Yes Yes No No Yes No No No 33.3
Rash Yes Yes Yes Yes No No No Yes Yes 66.7
Complications No Retinal vasculitis No No No No No No Septic shock NA
NA, not applicable.
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